The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: Implication for pathogenesis of Rett syndrome

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Miyake, Kunio ^a   Hirasawa, Takae ^a   Soutome, Masaki ^a   Itoh, Masayuki ^b   Goto, Yu Ichi ^b   Endoh, Kazushi ^a   Takahashi, Kenichiro ^c   Kudo, Shinichi ^d   Nakagawa, Takayuki ^e   Yokoi, Sana ^e   Taira, Takahiro ^a   Inazawa, Johji ^e   Kubota, Takeo ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d HOKKAIDO INSTITUTE OF PUBLIC HEALTH   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; SMALL INTERFERING RNA; CADHERIN; MECP2 PROTEIN, HUMAN; PCDH1 PROTEIN, HUMAN; PCDH7 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN TISSUE; CHROMATIN IMMUNOPRECIPITATION; DEREGULATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE; GENE EXPRESSION; GENOME; GENOMICS; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MICROARRAY ANALYSIS; MOUSE; MUTATIONAL ANALYSIS; NEUROBLASTOMA; NONHUMAN; PATHOGENESIS; PCDH7 GENE; PCDHB1 GENE; PROMOTER REGION; PROTEIN BINDING; RETT SYNDROME; SCREENING TEST; UPREGULATION; ANIMAL; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CADHERINS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; NEURONS; RETT SYNDROME; UP-REGULATION;

EID: 79961120015     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-81     Document Type: Article

References (58)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188. 10.1038/13810, 10508514.
2. Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437. 10.1016/j.neuron.2007.10.001, 17988628.
3. Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27:327-331. 10.1038/85906, 11242118.
4. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001, 27:322-326. 10.1038/85899, 11242117.
5. Kishi N, Macklis JD. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 2004, 27:306-321. 10.1016/j.mcn.2004.07.006, 15519245.
6. Pelka GJ, Watson CM, Radziewic T, Hayward M, Lahooti H, Christodoulou J, Tam PP. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 2006, 129:887-898. 10.1093/brain/awl022, 16467389.
7. Chao HT, Zoghbi HY, Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56:58-65. 10.1016/j.neuron.2007.08.018, 2198899, 17920015.
8. Tudor M, Akbarian S, Chen RZ, Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci (USA) 2002, 99:15536-15541.
9. Skene PJ, Illingworth RS, Webb S, Kerr AR, James KD, Turner DJ, Andrews R, Bird AP. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 2010, 37:457-468. 10.1016/j.molcel.2010.01.030, 20188665.
10. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229. 10.1126/science.1153252, 2443785, 18511691.
11. Kishi N, Macklis JD. MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Exp Neurol 2010, 222:51-58. 10.1016/j.expneurol.2009.12.007, 2846301, 20025874.
12. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889. 10.1126/science.1086446, 14593183.
13. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302:890-893. 10.1126/science.1090842, 14593184.
14. Nuber UA, Kriaucionis S, Roloff TC, Guy J, Selfridge J, Steinhoff C, Schulz R, Lipkowitz B, Ropers HH, Holmes MC, Bird A. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 2005, 14:2247-2256. 10.1093/hmg/ddi229, 16002417.
15. Jordan C, Li HH, Kwan HC, Francke U. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet 2007, 8:36. 1931432, 17584923.
16. Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M, Kubota T, Mori H, Tanaka S, Horie H, Tanabe Y, Goto Y. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J Neuropathol Exp Neurol 2007, 66:117-123. 10.1097/nen.0b013e3180302078, 17278996.
17. Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S, Pevsner J, Dissen GA, Sherman LS, Ojeda SR. FXYD1 is a MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 2007, 16:640-650.
18. Carouge D, Host L, Aunis D, Zwiller J, Anglard P. CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis 2010, 38:414-424. 10.1016/j.nbd.2010.02.014, 20211261.
19. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004, 95:559-563. 10.1111/j.1349-7006.2004.tb02486.x, 15245590.
20. Misawa A, Inoue J, Sugino Y, Hosoi H, Sugimoto T, Hosoda F, Ohki M, Imoto I, Inazawa J. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res 2005, 65:10233-10242. 10.1158/0008-5472.CAN-05-1073, 16288011.
21. Klose RJ, Sarraf SA, Schmiedeberg L, McDermott SM, Stancheva I, Bird AP. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 2005, 19:667-678. 10.1016/j.molcel.2005.07.021, 16137622.
22. Thatcher KN, Peddada S, Yasui DH, Lasalle JM. Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples. Hum Mol Genet 2005, 14:785-797. 10.1093/hmg/ddi073, 15689352.
23. Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci (USA) 2007, 104:9416-8421.
24. Carter AR, Segal RA. Rett syndrome model suggests MECP2 gives neurons the quiet they need to think. Nat Neurosci 2001, 4:342-343. 10.1038/85970, 11276217.
25. Laird PW. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 2010, 11:191-203.
26. Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 2003, 31:1765-1774. 10.1093/nar/gkg249, 152853, 12626718.
27. Nikitina T, Shi X, Ghosh RP, Horowitz-Scherer RA, Hansen JC, Woodcock CL. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol Cell Biol 2007, 27:864-877. 10.1128/MCB.01593-06, 1800686, 17101771.
28. Yagi T, Takeichi M. Cadherin superfamily genese: functions, genomic organaization, and neurologic diversity. Genes Dev 2000, 14:1169-1180.
29. Miki R, Hattori K, Taguchi Y, Tada MN, Isosaka T, Hidaka Y, Hirabayashi T, Hashimoto R, Fukuzako H, Yagi T. Identification and characterization of coding single-nucleotide polymorphisms within human protocadherin-alpha and -beta gene clusters. Gene 2005, 349:1-14.
30. Pedrosa E, Stefanescu R, Margolis B, Petruolo O, Lo Y, Nolan K, Novak T, Stopkova P, Lachman HM. Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia. Schizophr Res 2008, 102:210-219. 2862380, 18508241.
31. Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, Mukaddes NM, Balkhy S, Gascon G, Hashmi A, Al-Saad S, Ware J, Joseph RM, Greenblatt R, Gleason D, Ertelt JA, Apse KA, Bodell A, Partlow JN, Barry B, Yao H, Markianos K, Ferland RJ, Greenberg ME, Walsh CA. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223. 10.1126/science.1157657, 2586171, 18621663.
32. Gregório SP, Sallet PC, Do KA, Lin E, Gattaz WF, Dias-Neto E. Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Res 2009, 165:1-9. 10.1016/j.psychres.2007.08.011, 19054571.
33. Kalmady SV, Venkatasubramanian G. Evidence for positive selection on Protocadherin Y gene in Homo sapiens: implications for schizophrenia. Schizophr Res 2009, 108:299-300. 10.1016/j.schres.2008.09.015, 18938061.
34. Hirayama T, Yagi T. The role and expression of the protocadherin-alpha clusters in the CNS. Curr Opin Neurobiol 2006, 16:336-342. 10.1016/j.conb.2006.05.003, 16697637.
35. Yagi T. Clustered protocadherin family. Dev Growth Differ 2008, 50:S131-S140.
36. Junghans D, Heidenreich M, Hack I, Taylor V, Frotscher M, Kemler R. Postsynaptic and differential localization to neuronal subtypes of protocadherin beta16 in the mammalian central nervous system. Eur J Neurosci 2008, 27:559-571. 10.1111/j.1460-9568.2008.06052.x, 18279309.
37. Bauman ML, Kemper TL, Arin DM. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995, 45:1581-1586.
38. Armstrong D, Dunn JK, Antalffy B, Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 1995, 54:195-201. 10.1097/00005072-199503000-00006, 7876888.
39. Armstrong DD, Dunn K, Antalffy B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol 1998, 57:1013-1017. 10.1097/00005072-199811000-00003, 9825937.
40. Kawaguchi M, Toyama T, Kaneko R, Hirayama T, Kawamura Y, Yagi T. Relationship between DNA methylation states and transcription of individual isoforms encoded by the protocadherin-alpha gene cluster. J Biol Chem 2008, 283:12064-12075. 10.1074/jbc.M709648200, 18204046.
41. Yoshida K, Yoshitomo-Nakagawa K, Seki N, Sasaki M, Sugano S. Cloning, expression analysis, and chromosomal localization of BH-protocadherin (PCDH7), a novel member of the cadherin superfamily. Genomics 1998, 49:458-461. 10.1006/geno.1998.5271, 9615233.
42. Kim SY, Chung HS, Sun W, Kim H. Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain. Neuroscience 2007, 147:996-1021. 10.1016/j.neuroscience.2007.03.052, 17614211.
43. Etzrodt J, Krishna-K K, Redies C. Expression of classic cadherins and delta-protocadherins in the developing ferret retina. BMC Neurosci 2009, 10:153. 10.1186/1471-2202-10-153, 2811116, 20028529.
44. Yoshida K. Fibroblast cell shape and adhesion in vitro is altered by overexpression of the 7a and 7b isoforms of protocadherin 7, but not the 7c isoform. Cell Mol Biol Lett 2003, 8:735-741.
45. Yakabe S, Soejima H, Yatsuki H, Tominaga H, Zhao W, Higashimoto K, Joh K, Kudo S, Miyazaki K, Mukai T. MeCP2 knockdown reveals DNA methylation-independent gene repression of target genes in living cells and a bias in the cellular location of target gene products. Genes Genet Syst 2008, 83:199-208. 10.1266/ggs.83.199, 18506103.
46. Kohyama J, Kojima T, Takatsuka E, Yamashita T, Namiki J, Hsieh J, Gage FH, Namihira M, Okano H, Sawamoto K, Nakashima K. Epigenetic regulation of neural cell differentiation plasticity in the adult mammalian brain. Proc Natl Acad Sci (USA) 2008, 105:18012-18017.
47. Tsujimura K, Abematsu M, Kohyama J, Namihira M, Nakashima K. Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2. Exp Neurol 2009, 219:104-111. 10.1016/j.expneurol.2009.05.001, 19427855.
48. Maliszewska-Cyna E, Bawa D, Eubanks JH. Diminished prevalence but preserved synaptic distribution of N-methyl-d-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain. Neuroscience 2010, 168:624-632. 10.1016/j.neuroscience.2010.03.065, 20381590.
49. Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 2003, 302:826-830. 10.1126/science.1089071, 14593168.
50. Johnston MV, Blue ME, Naidu S. Rett syndrome and neuronal development. J Child Neurol 2005, 20:759-763.
51. Francke U. Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat Clin Pract Neurol 2006, 2:212-221. 10.1038/ncpneuro0148, 16932552.
52. Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I, Missler M, Zhang W. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 2008, 99:112-121.
53. Wood L, Shepherd GM. Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in a mutant mouse model of Rett syndrome. Neurobiol Dis 2010, 38:281-287. 10.1016/j.nbd.2010.01.018, 2854239, 20138994.
54. Zhang ZW, Zak JD, Liu H. MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol 2010, 103:2470-2481. 10.1152/jn.00601.2009, 2867574, 20200124.
55. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S, Inazawa J. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 2004, 64:3741-3747. 10.1158/0008-5472.CAN-04-0172, 15172977.
56. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB, Issa JP. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999, 59:2307-2312.
57. Hwang CK, Song KY, Kim CS, Choi HS, Guo XH, Law PY, Wei LN, Loh HH. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol 2007, 27:4720-4736. 10.1128/MCB.00073-07, 1951474, 17452465.
58. Taira T, Sawai M, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H. Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y. J Biol Chem 1999, 274:24270-24279. 10.1074/jbc.274.34.24270, 10446203.